Core B: Imaging/Marker Core
Core B: Imaging/Marker Core
批准号:
8079532
负责人:
LAWRENCE E MATHES
金额:
$22.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
未结题
起止时间:
2003-04-21 至
关键词:
AnimalsCellsComprehensive Cancer CenterConfocal MicroscopyCore ProteinCytometryData SetEnvironmentFlow CytometryImageImage AnalysisLaboratoriesLeadLifeMALDI-TOF Mass SpectrometryMass Spectrum AnalysisMeasuresMethodsMicroscopeNucleic AcidsPrintingProteinsPublicationsResearchResourcesSamplingServicesStaining methodStainsSystemTechniquesTechnologyTimeTrainingVirusWorkbasecost effectivedata acquisitionfootimaging modalityin vivoinhibitor/antagonistinstrumentinstrumentationnovelprotein distributionprotein protein interactionquality assurancetumor
中文摘要
PPG的核心B为所有项目在标准化细胞染色方法方面提供了重要支持
细胞术和共聚焦显微镜,协调活体动物成像,开发新的成像方法,
和新的蛋白质“足迹”质谱学方法。新的强大的蛋白质足迹
添加到核心B服务的技术提供有关蛋白质-核酸和蛋白质的详细信息
互动。成像-蛋白质核心将提供具有质量保证的公共资源
PPG中的五个项目。多用户仪器,包括徕卡共焦显微镜和MS in
VIVO成像系统由训练有素的技术人员以经济高效的方式使用。共聚焦成像是一种
PPG中几个关键项目的基本分析形式。使用MS进行活体动物成像
仪器设备正在迅速成为体内肿瘤纵向维氏时间分析的标准
分布和病毒表达,是竞争更新中的几项拟议工作所必需的。
AXIMA-CFR(MALDI-TOF)质谱仪是测定蛋白质、蛋白质、蛋白质的重要仪器。
核酸和蛋白质抑制剂,并已被添加为核心B服务。核心B在一个未完成的
环境方面,并记录了与包括许多科学出版物在内的所有项目的互动情况。
成像-蛋白质核心B的具体目标包括:1)提供标准化的细胞染色服务
将通过PPG成像核心进行共聚焦成像或通过流式细胞术进行分析的样本的
通过综合肿瘤中心分析细胞学实验室共享服务,2)
进行标准化研究,利用共聚焦显微镜成像进行定量分析
病毒和细胞蛋白的分布和亚细胞定位。提供培训和其他技术给
PPG用户组,3)协调对MS成像系统的访问并为PPG用户提供培训
小组,4)开发成像仪器的新应用,以增强PPG定向
研究和领导更精细的图像分析,5)使用质谱学(AXIMA-CFR MALDITOF)
基于蛋白质足迹技术的蛋白质-核酸和蛋白质的详细表征
互动。
英文摘要
Core B of the PPG provides important support for all projects in standardized cell staining methods for flow
cytometry and confocal microscopy, coordinates in vivo animal imaging, develops new imaging methods,
and novel protein "foot printing" mass spectrometry methods. The new powerful protein foot-printing
technology added to Core B services provides detailed information on protein-nucleic acid and proteinprotein
interactions. The Imaging-Protein Core will provide common resources with quality assurance to the
Five projects in the PPG. Multiuser instrumentation including the Leica Confocal Microscope and the MS in
vivo Imaging System are used in a cost effective manner by trained technicians. Confocal imaging is an
essential form of analysis for several key projects in the PPG. Live animal imaging using the MS
instrumentation is rapidly becoming the standard for in vivo longitudinal Veal time' analysis of tumor
distribution and virus expression and is essential for several of the proposed work in the competitive renewal.
The AXIMA-CFR (MALDI-TOF) mass spectrometry is a key instrument to measure protein-protein, protein
nucleic acid and protein-inhibitor, and has been added as a Core B service. Core B is within an outstanding
environment and has documented interactions with all projects including numerous scientific publications.
The Specific Aims of the Imaging-Protein Core B include: 1) To provide a standardized cell staining service
of samples that will be analyzed by either confocal imaging through the PPG Imaging Core, or flow cytometry
through the Analytical Cytometry Laboratory Shared Service of the Comprehensive Cancer Center, 2) To
conduct standardized studies that makes use of Confocal Microscopy imaging for the quantitative analysis of
virus and cell protein distribution and subcellular localization. To provide training and other techniques to the
PPG user group, 3) To coordinate access to the MS Imaging System and provide training to the PPG user
group, 4) To develop novel applications of the imaging instrumentation that will enhance the PPG directed
research and lead more refined image analysis, 5) To employ the mass spectrometry (AXIMA-CFR MALDITOF)
based protein foot printing technology for detailed characterization of protein-nucleic acid and proteinprotein
interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Do Psychostimulatory Drugs Enhance Lentivirus Infection?
-
批准号:7419096
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2007
-
负责人:LAWRENCE E MATHES
-
依托单位:
Do Psychostimulatory Drugs Enhance Lentivirus Infection?
-
批准号:7495018
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2007
-
负责人:LAWRENCE E MATHES
-
依托单位:
Evaluation of thymus function in lentivirus disease
-
批准号:7006335
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2005
-
负责人:LAWRENCE E MATHES
-
依托单位:
Evaluation of thymus function in lentivirus disease
-
批准号:7090854
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2005
-
负责人:LAWRENCE E MATHES
-
依托单位:
Evaluation of thymus function in lentivirus disease
-
批准号:7217943
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2005
-
负责人:LAWRENCE E MATHES
-
依托单位:
Evaluation of thymus function in lentivirus disease
-
批准号:7609053
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2005
-
负责人:LAWRENCE E MATHES
-
依托单位:
Evaluation of thymus function in lentivirus disease
-
批准号:7390264
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2005
-
负责人:LAWRENCE E MATHES
-
依托单位:
Core B: Imaging/Marker Core
-
批准号:7383674
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2003
-
负责人:LAWRENCE E MATHES
-
依托单位:
Core B: Imaging/Marker Core
-
批准号:7876679
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2003
-
负责人:LAWRENCE E MATHES
-
依托单位:
Core B: Imaging/Marker Core
-
批准号:8376226
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2003
-
负责人:LAWRENCE E MATHES
-
依托单位:
Core B: Imaging/Marker Core
-
批准号:8299999
-
项目类别:
-
资助金额:$22.03万
-
财政年份:2003
-
负责人:LAWRENCE E MATHES
-
依托单位:
PSYCHOSTIMULANTS AND LENTIVIRAL INFECTION OF NEURAL CELL
-
批准号:6661376
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2000
-
负责人:LAWRENCE E MATHES
-
依托单位:
PSYCHOSTIMULANTS AND LENTIVIRAL INFECTION OF NEURAL CELL
-
批准号:6515836
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2000
-
负责人:LAWRENCE E MATHES
-
依托单位:
PSYCHOSTIMULANTS AND LENTIVIRAL INFECTION OF NEURAL CELL
-
批准号:6755876
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2000
-
负责人:LAWRENCE E MATHES
-
依托单位:
ANTIVIRAL AGENTS EFFECTS ON IMMUNE FUNCTIONS
-
批准号:2389308
-
项目类别:
-
资助金额:$21.27万
-
财政年份:1997
-
负责人:LAWRENCE E MATHES
-
依托单位:
ANTIVIRAL AGENTS EFFECTS ON IMMUNE FUNCTIONS
-
批准号:6163716
-
项目类别:
-
资助金额:$23.24万
-
财政年份:1997
-
负责人:LAWRENCE E MATHES
-
依托单位:
ANTIVIRAL AGENTS EFFECTS ON IMMUNE FUNCTIONS
-
批准号:2667777
-
项目类别:
-
资助金额:$21.91万
-
财政年份:1997
-
负责人:LAWRENCE E MATHES
-
依托单位:
ANTIVIRAL AGENTS EFFECTS ON IMMUNE FUNCTIONS
-
批准号:2882218
-
项目类别:
-
资助金额:$22.56万
-
财政年份:1997
-
负责人:LAWRENCE E MATHES
-
依托单位:
HIGH & LOW DOSE AZT THERAPY MODULATES ANTIVIRAL IMMUNITY
-
批准号:3200694
-
项目类别:
-
资助金额:$21.78万
-
财政年份:1991
-
负责人:LAWRENCE E MATHES
-
依托单位:
HIGH & LOW DOSE AZT THERAPY MODULATES ANTIVIRAL IMMUNITY
-
批准号:2097218
-
项目类别:
-
资助金额:$23.4万
-
财政年份:1991
-
负责人:LAWRENCE E MATHES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: